Cargando…

Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach

INTRODUCTION: The influence of pre-existing humoral immunity, inter-individual demographic factors, and vaccine-associated reactogenicity on immunogenicity following COVID vaccination remains poorly understood. METHODS: Ten-fold cross-validated least absolute shrinkage and selection operator (LASSO)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Erin C., Kizhner, Alexander, Stark, Valerie S., Nawab, Aria, Muniz, Daniel D., Echeverri Tribin, Felipe, Carreño, Juan Manuel, Bielak, Dominika, Singh, Gagandeep, Hoffer, Michael E., Krammer, Florian, Pallikkuth, Suresh, Pahwa, Savita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949966/ https://www.ncbi.nlm.nih.gov/pubmed/36845120 http://dx.doi.org/10.3389/fimmu.2023.971277

Ejemplares similares

Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers
por: Pallikkuth, Suresh, et al.
Publicado: (2021)

IL-21 enhances influenza vaccine responses in aged macaques with suppressed SIV infection
por: Kvistad, Daniel, et al.
Publicado: (2021)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

Metabolic phenotype of B cells from young and elderly HIV individuals
por: Frasca, Daniela, et al.
Publicado: (2021)

Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida
por: Kupritz, Jonah, et al.
Publicado: (2023)

IL‐21‐IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection
por: Pallikkuth, Suresh, et al.
Publicado: (2023)

T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection
por: Pallikkuth, Suresh, et al.
Publicado: (2017)

Immunological age prediction in HIV-infected, ART-treated individuals
por: de Armas, Lesley R., et al.
Publicado: (2021)

Opioids exacerbate inflammation in people with well-controlled HIV
por: Dang, Christine M., et al.
Publicado: (2023)

Paediatric HIV infection in the ‘omics era: defining transcriptional signatures of viral control and vaccine responses
por: Cotugno, Nicola, et al.
Publicado: (2015)

Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty(®))
por: Held, Jürgen, et al.
Publicado: (2021)

Age Associated Microbiome and Microbial Metabolites Modulation and Its Association With Systemic Inflammation in a Rhesus Macaque Model
por: Pallikkuth, Suresh, et al.
Publicado: (2021)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
por: Lee, Jisun, et al.
Publicado: (2023)

A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
por: Pallikkuth, Suresh, et al.
Publicado: (2020)

Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study
por: Pallikkuth, Suresh, et al.
Publicado: (2019)

Impaired Antibody Response to Influenza Vaccine in HIV-Infected and Uninfected Aging Women Is Associated with Immune Activation and Inflammation
por: Parmigiani, Anita, et al.
Publicado: (2013)

Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
por: Carrico, Adam W., et al.
Publicado: (2020)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

953. Frailty Among People Living with HIV In Miami, A Cross Sectional Pilot Study
por: Salguero, Douglas, et al.
Publicado: (2020)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Single Cell Profiling Reveals PTEN Overexpression in Influenza-Specific B cells in Aging HIV-infected individuals on Anti-retroviral Therapy
por: de Armas, Lesley R., et al.
Publicado: (2019)

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India
por: Kausalya, Bagavathi, et al.
Publicado: (2022)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022)

Perturbation of B Cell Gene Expression Persists in HIV-Infected Children Despite Effective Antiretroviral Therapy and Predicts H1N1 Response
por: Cotugno, Nicola, et al.
Publicado: (2017)

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells
por: Pallikkuth, Suresh, et al.
Publicado: (2018)

The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019)

Reactogenicity of mRNA- and Non-mRNA-Based COVID-19 Vaccines among Lactating Mother and Child Dyads
por: Jacob-Chow, Beth, et al.
Publicado: (2022)

Immune Activation in HIV-Infected Aging Women on Antiretrovirals—Implications for Age-Associated Comorbidities: A Cross-Sectional Pilot Study
por: Alcaide, Maria L., et al.
Publicado: (2013)

Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients
por: Camargo, Jose F., et al.
Publicado: (2019)

Compromised steady‐state germinal center activity with age in nonhuman primates
por: Shankwitz, Kimberly, et al.
Publicado: (2019)

Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
por: Graydon, Elizabeth K., et al.
Publicado: (2023)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
por: de Armas, Lesley R., et al.
Publicado: (2021)

Methods for predicting vaccine immunogenicity and reactogenicity
por: Gonzalez-Dias, Patrícia, et al.
Publicado: (2019)

BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
por: Vizcarra, Pilar, et al.
Publicado: (2021)

25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
por: Bausk, Bruce P, et al.
Publicado: (2021)

2349. Natural Killer Cells and BNT162b2 mRNA Vaccine Reactogenicity and Durability
por: Graydon, Elizabeth K, et al.
Publicado: (2023)

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
por: Pardi, Norbert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4nu2uevhnhl857n390h7hvj1t6